Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer 2024-04-11 14:59
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study 2024-04-11 14:56
Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics 2024-04-10 21:15
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research 2024-04-10 21:00
Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024 2024-04-10 14:19
The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements 2024-04-09 23:14
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases 2024-04-09 22:00
Meeting the Future | TIANMA Makes a Strong Appearance at 2024 Embedded World 2024-04-09 22:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting 2024-04-09 19:00
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
China's Yunhong Group inks cooperation to support overseas expansion 2024-04-09 15:50
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib 2024-04-09 08:30
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR 2024-04-09 04:53
Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023 2024-04-09 04:45
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China 2024-04-08 22:00
Medit Unveils i900: The Next Evolution of Intraoral Scanners 2024-04-08 21:00
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals 2024-04-08 21:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego 2024-04-08 20:00
1 3 4 5 6 7 777